GoodRx

As a nurse practitioner, Jordan has seen firsthand the negative effects of high prescription costs on her patients. That’s why she regularly recommends GoodRx as a way to save on prescriptions, whether a patient has insurance or not. When an arthritis medication was going to cost her patient ~$300 with insurance, she immediately checked GoodRx. Her patient was able to save over 80%, bringing the price down to just $35. Jordan is just one of many healthcare professionals who recommend GoodRx to their patients. Check out our website or app and see if you can save. goodrx.co/goodstories

Living with lupus, Bea is often met with high medication costs and medical expenses. When she found out about GoodRx, she was astonished to see that she could save $1,600 on her prescriptions. Her husband Joe, a physician, recommends GoodRx to his patients everyday, helping them save money and access their prescribed treatments. We're happy to help GoodRx users and their loved ones save up to 80% on their prescription medications. Check GoodRx and see if you can save.

What lengths would you go to in order to afford your prescription medications? According to a new survey from GoodRx Research, over 60% of Americans see the cost of their prescription medications as a burden. And about 34% reported resorting to measures such as rationing or skipping medication due to cost concerns. See more results from our survey here: #affordability #prescriptions #healthcare #research

Millions of Americans rely on prescription medications each year. But how easy is it to get them, and how much are people really paying for them? The GoodRx Research Team ran a 3-month survey to try to answer these questions. See the results and methodology: #prescriptions #prescriptioncosts #research

The US government is now negotiating some drug prices. So what does it mean? Today, we finally learned the outcome of negotiations between the U.S. government and pharmaceutical companies to lower Medicare prices for select prescription medications as part of the Inflation Reduction Act (IRA). At GoodRx, we support all efforts to lower the cost of medications for consumers. Since 2011, we’ve remained steadfast in our belief that people are simply paying too much to stay healthy. We work hard every single day to change this reality so consumers no longer need to choose between protecting their health and paying for life’s other essential expenses. Today’s news is a step in the right direction. Only 10 brand-name medications were included in the initial IRA negotiations. These medications represent minimal volume on GoodRx’s prescription marketplace - only .1% of our claims in July 2024, for example. While the negotiated prices will save Medicare billions of dollars, these reductions likely won’t have a significant impact on how much patients pay. Consumer out-of-pocket costs will continue to be dictated by the benefit design of their specific insurance plans, not the price ceilings for the medications themselves. This is why bringing cash price savings opportunities to consumers remains so important. GoodRx works directly with manufacturers of brand-name medications to bring their savings and support programs to consumers. For example, last year we partnered with Sanofi to make the insulin Lantus available for $35 at 70,000 pharmacies. This year, we partnered with Boehringer Ingelheim to provide Adalimumab-adbm, an FDA-approved interchangeable biosimilar to Humira, at a 92% discount from the Humira list price. These are just two of the many ways we’re bringing cost savings directly to the patients who need these discounts most. Looking forward, our sights are set on continuing to improve affordability for consumers and establishing additional cash savings opportunities for the medications our users rely on to maintain good health. Today, we have contracted cash programs with almost 40 brand medications, and we expect to add a number of high-impact brands over the next few quarters. We’re continuing our conversations with several pharma manufacturers to provide more affordable ways for people to access medications and welcome the opportunity to work with those outlined in today’s news. While these negotiations may not have a transformational impact on consumer’s wallets, they do draw attention to the outrageous costs placed on people who are just trying to access basic healthcare. We look forward to continuing to work with patients, physicians, pharmaceutical manufacturers and pharmacies to produce meaningful change.

Mark Stetson, Vice President of Sales and Account Management at GoodRx, will be joining Cervey to introduce you to a solution to bridge the gap for your patients. Join them Wednesday, August 28th at 2:00PM CST to "Reimagine Rejections: Less Friction for Patients. More Visibility for PBMs." Register HERE: https://buff.ly/4cgey6X

GoodRx Research and collaborators from Harvard Medical School find that nearly half of U.S. counties don’t have a single cardiologist. Many of these counties are rural and have a higher risk of cardiovascular disease. See the details of our findings here: #healthcareaccess #hearthealth #research

We need your votes! GoodRx’s Chief Commercial Officer Dorothy Gemmell is being considered to speak at SXSW 2025 alongside two other women’s health trailblazers, Pfizer's Aditi Goenka and Elektra Health’s Alessandra Henderson. Together, these three healthcare industry leaders will shed light on how the healthcare cost crisis disproportionately impacts women across all conditions, and address how we can tackle lowering costs to support a healthier population and relieve pressure on our healthcare system. ✅ Vote for “The Hidden Pink Tax Fueling High Healthcare Costs for Women” today through Aug. 18: https://lnkd.in/eZ2Q-ei4 #SXSW #SXSW2025 #PanelPicker #WomensHealth

Meet some of the newest GoodRxers! We're excited to welcome more of GoodRx's recent new hires. Serap Aydogdu, Amanda Carlson, Brittney (Posey) Davis, Andrey Belostotsky, Snigdha Kansal, Elsie Yi, Alex Bauguess Hickey, Brandon Castaing, Jacob Hurwith, Erik Knapp, Erin Duenwald, and Hannah Holtzman

Medicine has changed and evolved through the years. According to our expert pharmacists, these drugs and vaccines approved in 2024 represent major advancements in medical science. #FDAapproval #prescriptions #healthcare